Mukesh Harisinghani, MD
Diagnostic Radiology · Boston, MANPI 1659345361
Payments from drug & device makers
Across 655 payments — averaging $3773.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Perspectum Diagnostics Ltd$1M
- AbbVie$312K
- Merck$291K
- E.r. Squibb & Sons, L.L.C.$183K
- Takeda Pharmaceuticals U.S.A., Inc.$117K
- Siemens Medical Solutions USA, Inc.$117K
- plus $439K from 19 others
Across 3 payments — averaging $839.03 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Regeneron$2K
- Novartis$917
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Perspectum Diagnostics Ltd | 54 | $1,012,148 |
| AbbVie | 83 | $312,455 |
| Merck | 232 | $291,401 |
| E.r. Squibb & Sons, L.L.C. | 9 | $182,515 |
| Takeda Pharmaceuticals U.S.A., Inc. | 62 | $117,040 |
| Siemens Medical Solutions USA, Inc. | 25 | $116,513 |
| GE HealthCare | 46 | $107,588 |
| Dr.reddy's Laboratories,inc. | 44 | $74,530 |
| Beigene, Ltd. | 36 | $66,355 |
| AstraZeneca | 3 | $41,160 |
| Astrazeneca UK Limited | 3 | $29,396 |
| Novartis | 4 | $29,055 |
| Beigene (suzhou) Co., Ltd. | 3 | $21,255 |
| EMD Serono, Inc. | 5 | $15,640 |
| Vertex | 5 | $13,230 |
| Eisai Inc. | 7 | $8,120 |
| Pfizer | 6 | $6,060 |
| GSK | 5 | $5,691 |
| Acerta Pharma LLC | 2 | $4,882 |
| Guerbet LLC | 11 | $4,186 |
| AMAG Pharmaceuticals, Inc. | 2 | $3,615 |
| Bayer | 1 | $3,250 |
| Eli Lilly | 1 | $2,800 |
| Janssen Research & Development, LLC | 5 | $2,470 |
| Roche Products Limited | 1 | $200 |
How this compares
$2,471,554 in reported general payments places this provider in the 95th percentile of 1,206 diagnostic radiology providers in Massachusetts.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other diagnostic radiology in Boston
- Stephan AndersonBoston$4.8M
- Gregg MillerBoston$4.2M
- Anthony SamirBoston$2.5M
- Albert YooBoston$2.1M
- Andrew KompelBoston$2M
- Ashraf ThabetBoston$2M
- Subba DigumarthyBoston$1.7M
- Udo HoffmannBoston$1.7M
- Clare TempanyBoston$1.5M
- Avinash Kambadakone RameshBoston$956K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.